Finally, to assess KLF2 binding to the IRF4 promoter in MM cells, we carried out ChIP assays in RPMI8226 cells using antibody against KLF2 or control IgG, followed by QRT–PCR. This evidence concerns the gene IRF4 and Miyoshi myopathy.